• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发肿瘤体积广泛侵犯对接受调强放疗的 T3-4 期鼻咽癌的预后疗效。

Prognostic efficacy of extensive invasion of primary tumor volume for T3-4 nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.

机构信息

Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Shanghai 200032, China.

Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Shanghai 200032, China.

出版信息

Oral Oncol. 2020 Jan;100:104478. doi: 10.1016/j.oraloncology.2019.104478. Epub 2019 Nov 20.

DOI:10.1016/j.oraloncology.2019.104478
PMID:31759331
Abstract

OBJECTIVES

This study aimed to explore the prognostic value of extensive invasion of primary tumor volume for local control in patients with T3-4 NPC receiving intensity-modulated radiotherapy (IMRT).

MATERIALS AND METHODS

Between January 2009 and December 2015, initial volume of GTV-P, the confined and extensive invasion part of GTV-P (GTV-C and GTV-E) were obtained from 159 prospectively enrolled non-metastatic T3-4 NPC patients. GTV-E included the tumor with infiltration of bony structures at skull base, cervical vertebra, paranasal sinuses or with intracranial extension. GTV-C was calculated by the subtraction of GTV-E from GTV-P. The effects of tumor volume levels on local control rate (LC) were evaluated by Kaplan-Meier method and multivariate analysis.

RESULTS

GTV-P (P = 0.015) and GTV-E (P = 0.001) were significantly correlated with local failure, while GTV-C (P = 0.494) was not. Then optimal cut-off values of GTV-P (43 mL) and GTV-E (22 mL) were determined by receiver operating characteristic curve analysis. Patients with small (<22 mL) GTV-E achieved better 5-year LC rate than those with large (≥22 mL) GTV-E (96.3% vs.76.1%, P < 0.001), but no significant difference was found between patients with small (<43 mL) and large (≥43 mL) GTV-P (95.9% vs. 85.5%, P = 0.094). Multivariate analysis also demonstrated large (≥22 mL) GTV-E to be an independent unfavorable prognostic factor for LC (hazard ratio [HR], 3.805; 95% CI, 1.100-13.166; P = 0.035).

CONCLUSION

GTV-E is an independent prognostic factor for LC in T3-4 NPC and may further assist in the optimization of treatment strategies.

摘要

目的

本研究旨在探讨原发性肿瘤体积广泛侵犯对接受调强放疗(IMRT)的 T3-4 NPC 患者局部控制的预后价值。

材料和方法

2009 年 1 月至 2015 年 12 月,前瞻性纳入 159 例非转移性 T3-4 NPC 患者,获取 GTV-P、GTV-P 的局限和广泛侵犯部分(GTV-C 和 GTV-E)的初始体积。GTV-E 包括颅骨底部、颈椎、副鼻窦或颅内侵犯的肿瘤。GTV-C 通过从 GTV-P 中减去 GTV-E 计算得出。通过 Kaplan-Meier 方法和多变量分析评估肿瘤体积水平对局部控制率(LC)的影响。

结果

GTV-P(P=0.015)和 GTV-E(P=0.001)与局部失败显著相关,而 GTV-C(P=0.494)则没有。然后通过接受者操作特征曲线分析确定 GTV-P(43mL)和 GTV-E(22mL)的最佳截止值。GTV-E 较小(<22mL)的患者 5 年 LC 率优于 GTV-E 较大(≥22mL)的患者(96.3%比 76.1%,P<0.001),但 GTV-P 较小(<43mL)和较大(≥43mL)的患者之间无显著差异(95.9%比 85.5%,P=0.094)。多变量分析也表明,GTV-E 较大(≥22mL)是 LC 的独立不良预后因素(风险比[HR],3.805;95%置信区间,1.100-13.166;P=0.035)。

结论

GTV-E 是 T3-4 NPC 局部控制的独立预后因素,可能有助于进一步优化治疗策略。

相似文献

1
Prognostic efficacy of extensive invasion of primary tumor volume for T3-4 nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.原发肿瘤体积广泛侵犯对接受调强放疗的 T3-4 期鼻咽癌的预后疗效。
Oral Oncol. 2020 Jan;100:104478. doi: 10.1016/j.oraloncology.2019.104478. Epub 2019 Nov 20.
2
Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.局部晚期鼻咽癌患者接受调强放疗时肿瘤体积的预后价值及预测阈值
Chin J Cancer. 2016 Nov 16;35(1):96. doi: 10.1186/s40880-016-0159-2.
3
Impact of minimum point dose on local control and toxicity in T3-4 nasopharyngeal carcinoma treated with intensity-modulated radiation therapy plus chemotherapy.调强放疗联合化疗治疗T3-4期鼻咽癌时最小剂量点对局部控制和毒性的影响
Jpn J Clin Oncol. 2018 Mar 1;48(3):265-271. doi: 10.1093/jjco/hyx183.
4
Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma?调强放疗鼻咽癌时原发肿瘤体积仍是预后因素吗?
Radiother Oncol. 2012 Sep;104(3):294-9. doi: 10.1016/j.radonc.2012.09.001. Epub 2012 Sep 19.
5
Prognostic scoring system for locoregional control among the patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy.调强放射治疗鼻咽癌患者局部区域控制的预后评分系统
Chin J Cancer. 2013 Sep;32(9):494-501. doi: 10.5732/cjc.013.10121. Epub 2013 Aug 28.
6
Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma.调强放疗用于局部复发性T3至T4期鼻咽癌的再程放疗。
Head Neck. 2017 Mar;39(3):533-540. doi: 10.1002/hed.24645. Epub 2016 Nov 29.
7
Magnetic Resonance Imaging-Detected Intracranial Extension in the T4 Classification Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy.磁共振成像检测T4期鼻咽癌调强放疗后的颅内侵犯情况
Cancer Res Treat. 2017 Apr;49(2):518-525. doi: 10.4143/crt.2016.299. Epub 2016 Aug 24.
8
Paranasal Sinus Invasion in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.调强放疗后鼻咽癌的鼻窦侵犯。
Cancer Res Treat. 2019 Jan;51(1):73-79. doi: 10.4143/crt.2017.607. Epub 2018 Feb 26.
9
Paranasal sinus invasion suggested T4 classification of patients of nasopharyngeal carcinoma: A two-center retrospective investigation.建议将鼻窦侵犯的鼻咽癌患者分类为 T4 期:一项来自两个中心的回顾性研究。
Head Neck. 2019 Dec;41(12):4088-4097. doi: 10.1002/hed.25953. Epub 2019 Sep 13.
10
Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.调强放疗治疗鼻咽癌:8 期 AJCC 分期 IVa 亚组的临床结果和失败模式。
Eur Radiol. 2020 Feb;30(2):816-822. doi: 10.1007/s00330-019-06500-5. Epub 2019 Oct 24.

引用本文的文献

1
Study on the radiotherapy effect and serum neutral granulocyte lymphocyte ratio and inflammatory factor expression of nasopharyngeal carcinoma.鼻咽癌放疗效果及血清中性粒细胞淋巴细胞比值与炎症因子表达的研究
Open Med (Wars). 2024 Jan 16;19(1):20230842. doi: 10.1515/med-2023-0842. eCollection 2024.
2
Efficacy of concurrent chemoradiotherapy alone for loco-regionally advanced nasopharyngeal carcinoma: long-term follow-up analysis.单纯同期放化疗治疗局部晚期鼻咽癌的疗效:长期随访分析。
Radiat Oncol. 2023 Apr 5;18(1):63. doi: 10.1186/s13014-023-02247-y.
3
Is a high-risk clinical target volume required? Evaluation of the dosimetric feasibility based on T staging.
是否需要高危临床靶区?基于T分期的剂量学可行性评估。
Front Oncol. 2022 Sep 2;12:800400. doi: 10.3389/fonc.2022.800400. eCollection 2022.
4
Residual Volume of Lymph Nodes During Chemoradiotherapy Based Nomogram to Predict Survival of Nasopharyngeal Carcinoma Patient Receiving Induction Chemotherapy.基于放化疗的鼻咽癌诱导化疗患者生存预测列线图中淋巴结的残余体积
Front Oncol. 2021 Sep 6;11:739103. doi: 10.3389/fonc.2021.739103. eCollection 2021.
5
Establishment of a Prognostic Nomogram for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Incorporating TNM Stage, Post-Induction Chemotherapy Tumor Volume and Epstein-Barr Virus DNA Load.纳入TNM分期、诱导化疗后肿瘤体积和爱泼斯坦-巴尔病毒DNA载量的局部晚期鼻咽癌患者预后列线图的建立。
Front Oncol. 2021 Jun 16;11:683475. doi: 10.3389/fonc.2021.683475. eCollection 2021.